NasdaqGS:VTRSPharmaceuticals
Viatris (VTRS) Quarterly Loss Of US$340.1 Million Tests Profitability Turnaround Narrative
Recent results put Viatris's profitability under the microscope
Viatris (VTRS) has just posted its FY 2025 numbers, with fourth quarter revenue of US$3,703.6 million and a basic EPS loss of US$0.30, while trailing twelve month revenue came in at US$14.3 billion alongside a basic EPS loss of US$3.00. Over recent periods, the company has seen quarterly revenue move from US$3,528.1 million in Q4 2024 to US$3,703.6 million in Q4 2025, with basic EPS shifting from a loss of US$0.43 to a loss of...